Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. - Wikidata - awgldk - TriplyDB

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

http://www.wikidata.org/entity/Q37385973

about

Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse.Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton.Stemming bone loss by suppressing apoptosis.Metabolic bone disease in adults with inflammatory bowel disease.Proteomics in bone research.Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.Osteoporosis in systemic lupus erythematosus: prevention and treatment.Role of teriparatide in treatment of glucocorticoid-induced osteoporosis 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats.Parathyroid hormone for the treatment of osteoporosis: a systematic review.Osteoporosis in the rheumatic disease patient.Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.Novel treatments for osteoporosis.Prevention of glucocorticoid induced bone changes with beta-ecdysone.Glucocorticoid dose determines osteocyte cell fate.Medical treatment of vertebral osteoporosis Steroids cause osteoporosis.How to prevent steroid induced osteoporosis.Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.Disorders associated with acute rapid and severe bone loss.Teriparatide for severe osteoporosis.Treatment of osteoporosis in men.Risk factors for osteoporosis in female patients with systemic lupus erythematosus.Local and systemic control of the osteoblast.Molecular and cellular mechanisms of the anabolic effect of intermittent PTH Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis Treatment of glucocorticoid-induced osteoporsis Glucocorticoid-induced osteoporosis: treatment update and review.Pulsatile release of parathyroid hormone from an implantable delivery system.Parathyroid hormone (1-84) and treatment of osteoporosis.Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta-Analysis.

P2860

Q24805600-6F376028-D1E5-49FD-8D5C-77086F35CAF3 Q24806684-9880F1B6-D6AE-45A6-B5A1-C45152CFC34B Q28573174-8D1AEB87-E48E-47A1-A81C-31E135C06628 Q30946308-B437C029-B8BE-4EBC-8A5B-CAFF0238C377 Q31032314-240C4434-3879-4272-A338-8DE365299BCD Q33320934-88448DDE-14A3-4821-8688-67C03914F0C7 Q33660658-4CE59BEA-A59A-431C-846A-AFEB41581D73 Q33712675-7BB9D75E-79A4-410B-BA91-ED23EE2D9106 Q33715517-7AC1D619-5D5F-4CB4-9C50-99416E8443DD Q33767411-4E016F9E-9476-405C-91C1-C5848C18E867 Q33857424-46B3B5C2-2C69-4BA1-A2A3-05042F4FF009 Q33874504-1D8BF1E3-7D68-4B22-A460-2616F73E158A Q34069674-2FDDCA7A-D919-47D9-AA30-0C99F9FE03A0 Q34142098-D16676FD-3B02-4CBC-8DA8-0E27E4E37FE5 Q34227091-D9CB2BED-B022-402D-8AD4-22A11478D58B Q34235921-8BA78656-7076-4711-A268-C389AC795064 Q34300668-623AF134-B7FD-4630-AB07-995A66301A79 Q34433399-D67E374A-6A4E-4183-BCCE-C2A4554D6754 Q34695988-75B78DD3-FD1D-442A-A720-51AD360D9A75 Q34986976-912AB47C-DD61-46CC-97B8-217CA30DCF9F Q35026459-C51D228C-67DE-4AC2-9FF9-E96DDC1683E3 Q35126745-42F84482-903C-43C6-8E55-CBFE4535DC28 Q35163490-53F63EA8-9FE4-4A00-AAF0-259DFF10E346 Q35225093-DFF39DF4-8F9D-481B-85B5-154CF3F4F0B2 Q35299212-75073BB8-5419-4C86-9B07-BC2A8D6C4F1B Q35550904-FE373C11-0DAA-4798-9920-6530429161CD Q35555248-432397D4-28DD-4FDC-ADC7-E1ACFDA31082 Q35601856-F95C416D-0CC5-4AAE-A564-AB8087EAC0C6 Q35606552-60EA30AC-7BD6-48DC-A941-DE70436A04CE Q35637987-4D894366-16F8-4AFA-9F16-0E98CB79D74A Q35895418-2380ACE5-49CE-4EC8-84F5-3D2370D9468D Q35918391-4A82B62B-C087-43DD-B30F-E9CD7774C2CB Q36010759-E37185CC-5CCE-4ED7-9F9F-A2E3E57C5F84 Q36016775-94883BFF-8566-4FC5-AFDF-28AF485DCE00 Q36045845-3D9227ED-2BF4-4DDE-95F3-2095431F8216 Q36056932-CF74379A-7F6C-4AA6-A6C7-B058B59FB770 Q36059394-3F4E5A0A-6A44-4EBF-A714-CF94E199570A Q36102547-C0702F69-2990-43A4-B512-4DCDFB980E19 Q36217215-C935A24E-F8C4-4330-AF9F-EC58658C8469 Q36229660-0C7DDAEC-58D8-41AC-924F-E584F4A6DD3F

P2860

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

http://www.wikidata.org/entity/Q37385973

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1998

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Parathyroid hormone treatment ...... zed controlled clinical trial.

@en

Parathyroid hormone treatment ...... zed controlled clinical trial.

@nl

type

label

Parathyroid hormone treatment ...... zed controlled clinical trial.

@en

Parathyroid hormone treatment ...... zed controlled clinical trial.

@nl

prefLabel

Parathyroid hormone treatment ...... zed controlled clinical trial.

@en

Parathyroid hormone treatment ...... zed controlled clinical trial.

@nl

P1433

Q37385973-B5EFE4B5-3C1E-4F66-8106-AF17B0D2BC15

P1476

Q37385973-90976FA1-916A-413F-A2B3-14C761BFDBE8

P2093

Q37385973-04041BF8-C376-4F56-9698-839C5AB577EB

Q37385973-2BD205F1-ED80-4315-B799-FFBF0A17659A

Q37385973-34A2B856-CDAA-4895-960F-FDD17AE12426

Q37385973-9AECE01B-3891-4A65-9935-380DF25EC923

Q37385973-EA7FB617-20F5-4DF7-B014-29287244CF19

Q37385973-FEF392B7-679D-4867-8CA7-5ED326816E99

P2860

Q37385973-0A0D055C-E9E5-4436-A98D-3791B7FE64D8

Q37385973-2B46872C-B82B-48F8-9386-8FA3932089EF

Q37385973-42C60F34-51B5-43EB-AC80-6996B316FBD5

Q37385973-5035266C-44A3-49FC-A133-D292D14AACF0

Q37385973-556FE929-E168-468A-80D9-9AC57CDAFCCE

Q37385973-633EA068-0C80-4D89-B1E2-1DE9C3889CC5

Q37385973-939D2A0A-57D2-4ED8-B03E-667F376B18E8

Q37385973-B0987B55-6787-4826-B345-146580F27426

Q37385973-D6B78B4E-8E75-4D7D-88BB-7EE5CDB0D290

Q37385973-DAEC14E9-3131-4004-9DA6-E61989480CC1

P304

Q37385973-1484A3CF-82CA-44AB-82A0-10DE69E28CF1

P31

Q37385973-4A6FCE82-B96D-4EF2-A09C-3C865B4B7997

P356

Q37385973-9D5921A6-D53E-4F6B-8AD5-B884059D7BFD

P407

Q37385973-DDA9E262-9072-4A15-A978-EE41C1FCB30E

P433

Q37385973-F1AFD03F-8B34-4B2B-AD2A-08D97F254CE9

P478

Q37385973-55D4BC37-3488-4DA2-A2B1-15036EF0F942

P577

Q37385973-E68CFA39-A06D-49BA-9D10-30B69D841413

P5875

Q37385973-B7B40C16-2423-4548-AF95-80D3508437C3

P698

Q37385973-CFCAF380-D483-47CF-A8F9-72E6A88411B7

P921

Q37385973-AA9060A1-9171-47F2-B852-E94381BE9CD7

P932

Q37385973-713E7410-8B0A-4B1C-B406-45A246304E64

P356

P1433

Journal of Clinical Investigation

P1476

Parathyroid hormone treatment ...... zed controlled clinical trial.

@en

P2093

C D Arnaud

http://www.w3.org/2001/XMLSchema#string

E Pierini

http://www.w3.org/2001/XMLSchema#string

G W Modin

http://www.w3.org/2001/XMLSchema#string

H K Genant

http://www.w3.org/2001/XMLSchema#string

N E Lane

http://www.w3.org/2001/XMLSchema#string

S Sanchez

http://www.w3.org/2001/XMLSchema#string

P2860

An evaluation of antibodies and clinical resistance to salmon calcitonin

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Parathyroid hormone receptor in intact embryonic chicken bone: characterization and cellular localization.

The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.

Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures.

Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery.

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

P304

1627-1633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI3914

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

1998-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13497363

http://www.w3.org/2001/XMLSchema#string

P698

9788977

http://www.w3.org/2001/XMLSchema#string

P921

P932

509014

http://www.w3.org/2001/XMLSchema#string